These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Müller B. Crit Care; 2005 Feb; 9(1):R37-45. PubMed ID: 15693965 [Abstract] [Full Text] [Related]
4. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL. J Am Coll Cardiol; 2007 Apr 10; 49(14):1525-32. PubMed ID: 17418290 [Abstract] [Full Text] [Related]
5. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V, FINNSEPSIS Study Group. Crit Care Med; 2007 May 10; 35(5):1277-83. PubMed ID: 17414731 [Abstract] [Full Text] [Related]
6. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T. J Card Fail; 2007 Feb 10; 13(1):42-9. PubMed ID: 17339002 [Abstract] [Full Text] [Related]
7. Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin. Wang RL, Kang FX. Chin J Traumatol; 2010 Jun 01; 13(3):152-7. PubMed ID: 20515592 [Abstract] [Full Text] [Related]
9. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Hynninen M, Pettilä V, Takkunen O, Orko R, Jansson SE, Kuusela P, Renkonen R, Valtonen M. Shock; 2003 Jul 01; 20(1):1-4. PubMed ID: 12813360 [Abstract] [Full Text] [Related]
10. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Maisel A, Mueller C, Nowak RM, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng LL, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Hartmann O, Morgenthaler NG, Anker SD. J Am Coll Cardiol; 2011 Aug 30; 58(10):1057-67. PubMed ID: 21867843 [Abstract] [Full Text] [Related]
11. Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction. Elmas E, Lang S, Dempfle CE, Kälsch T, Papassotiriou J, Morgenthaler NG, Borggrefe M, Brueckmann M. Int J Cardiol; 2008 Aug 01; 128(1):107-11. PubMed ID: 17698224 [Abstract] [Full Text] [Related]
12. Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients. Haaf P, Twerenbold R, Reichlin T, Faoro J, Reiter M, Meune C, Steuer S, Bassetti S, Ziller R, Balmelli C, Campodarve I, Zellweger C, Kilchenmann A, Irfan A, Papassotiriou J, Drexler B, Mueller C. Int J Cardiol; 2013 Sep 30; 168(2):1048-55. PubMed ID: 23199555 [Abstract] [Full Text] [Related]
13. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Müller B. Endothelium; 2007 Sep 30; 14(6):345-51. PubMed ID: 18080871 [Abstract] [Full Text] [Related]
14. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD. J Am Coll Cardiol; 2010 May 11; 55(19):2062-76. PubMed ID: 20447528 [Abstract] [Full Text] [Related]
15. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. Enguix-Armada A, Escobar-Conesa R, García-De La Torre A, De La Torre-Prados MV. Clin Chem Lab Med; 2016 Jan 11; 54(1):163-8. PubMed ID: 26083268 [Abstract] [Full Text] [Related]
16. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G. Crit Care Med; 2007 Oct 11; 35(10):2268-73. PubMed ID: 17717488 [Abstract] [Full Text] [Related]
17. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Kotanidou A, Karsaliakos P, Tzanela M, Mavrou I, Kopterides P, Papadomichelakis E, Theodorakopoulou M, Botoula E, Tsangaris I, Lignos M, Ikonomidis I, Ilias I, Armaganidis A, Orfanos SE, Dimopoulou I. Shock; 2009 Apr 11; 31(4):342-7. PubMed ID: 18791494 [Abstract] [Full Text] [Related]
18. [The study on pro-adrenomedullin as a new biomarker in sepsis prognosis and risk stratification]. Kang FX, Wang RL, Yu KL, Wei Q. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug 11; 20(8):452-5. PubMed ID: 18687169 [Abstract] [Full Text] [Related]
19. Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis. Schulte J, Struck J, Köhrle J, Müller B. Shock; 2011 May 11; 35(5):460-5. PubMed ID: 21283059 [Abstract] [Full Text] [Related]
20. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections. Angeletti S, Spoto S, Fogolari M, Cortigiani M, Fioravanti M, De Florio L, Curcio B, Cavalieri D, Costantino S, Dicuonzo G. APMIS; 2015 Sep 11; 123(9):740-8. PubMed ID: 26058482 [Abstract] [Full Text] [Related] Page: [Next] [New Search]